SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

KREBS BIOCHEMICALS & INDUSTRIE

BSE: 524518 09 Sep 2025
Healthcare
₹ 72.65
Krebs Biochemicals & Industries Ltd. specializes in Pharmaceuticals within the Healthcare sector.

KREBS BIOCHEMICALS & INDUSTRIE - Share Price & Details

Market Cap
₹189.0
High /Low
129.0 / 63.6
Stock P/E
NA
Book Value
₹-67.8
Dividend Yield
0.0
ROCE
-29.9
ROE
₹NA
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹-28.0
Debt
212
CMP / FCF
-11.0
Debt to equity
₹NA
NP Ann
-26.9
High price all time
228.0
Piotroski score
₹2.0
Graham Number
NA
No. Eq. Shares
2.16
Net CF
₹0.00
Net profit
-26.9
Price to book value
NA
Interest Coverage
₹-3.55
Low price all time
9.08
Industry PE
33.8
Reserves
₹-168
Free Cash Flow
₹-11.3

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
KREBS BIOCHEMICALS & INDUSTRIE54.93-53.2454.81-2.47189.0
BILCARE LTD.NANANANA18630.2
BDH INDUSTRIES LTD.NANANANA18319.1

Peer Comparison Chart


About KREBS BIOCHEMICALS & INDUSTRIE

Krebs Biochemicals & Industries Ltd., with Security Code 524518, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Krebs Biochem Standalone June 2025 Net Sales at Rs 5.48 crore, down 57.48% Y-o-Y

(22 Aug 2025)
Net Sales at Rs 5.48 crore in June 2025 down 57.48% from Rs. 12.89 crore in June 2024. Story continues below Advertisement.
Read more →

KREBS BIOCHEMICALS Share Price Today Up 5%

(19 Aug 2025)
Real-time updates on KREBS BIOCHEMICALS share price. Check out the detailed analysis of the company in this live blog.
Read more →

Edelweiss Financial Services reports standalone net profit of Rs 65.34 crore in the June 2025 quarter

(10 Aug 2025)
Net profit of Edelweiss Financial Services reported to Rs 65.34 crore in the quarter ended June 2025 as against net loss of Rs 88.66 crore...
Read more →

Krebs Biochemicals Reports Mixed Financial Results Amidst Operational Challenges in June 2025

(09 Aug 2025)
Krebs Biochemicals & Industries has reported mixed financial results for the quarter ending June 2025. While the company achieved its highest operating...
Read more →

Krebs Biochemicals & Industries reports standalone net loss of Rs 5.32 crore in the June 2025 quarter

(07 Aug 2025)
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.32 crore in the quarter ended June 2025 as against net loss of Rs 5.17 crore during the...
Read more →

Why is GTN.A stock attracting strong analyst attention - Market-crushing profits

(28 Jul 2025)
【Stock Buzz】✌️ Let us help you avoid mediocre returns and focus only on high-growth plays that have delivered 200% or more.
Read more →

Company Updates